Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes.

Georgakopoulou, Vasiliki E; Lembessis, Panagiotis; Skarlis, Charalampos; Gkoufa, Aikaterini; Sipsas, Nikolaos V; Mavragani, Clio P

Georgakopoulou, Vasiliki E; Lembessis, Panagiotis; Skarlis, Charalampos; Gkoufa, Aikaterini; Sipsas, Nikolaos V; Mavragani, Clio P.

Afiliação

Georgakopoulou VE; Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Lembessis P; Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Skarlis C; Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Gkoufa A; Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Sipsas NV; Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Mavragani CP; Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Front Med (Lausanne) ; 9: 850472, 2022.

Article em En | MEDLINE | ID: mdl-35372456

Palavras-chave

COVID-19; cytopenias; eosinopenia; eosinophils; lymphopenia; platelets; type I interferon; white blood cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google